187 related articles for article (PubMed ID: 34496552)
1. QbD-based Formulation Optimization and Characterization of Polymeric Nanoparticles of Cinacalcet Hydrochloride with Improved Biopharmaceutical Attributes.
Ghose D; Patra CN; Ravi Kumar BVV; Swain S; Jena BR; Choudhury P; Shree D
Turk J Pharm Sci; 2021 Sep; 18(4):452-464. PubMed ID: 34496552
[TBL] [Abstract][Full Text] [Related]
2. Raloxifene-loaded SLNs with enhanced biopharmaceutical potential: QbD-steered development, in vitro evaluation, in vivo pharmacokinetics, and IVIVC.
Jain A; Sharma T; Kumar R; Katare OP; Singh B
Drug Deliv Transl Res; 2022 May; 12(5):1136-1160. PubMed ID: 33966178
[TBL] [Abstract][Full Text] [Related]
3. QbD enabled optimization of solvent shifting method for fabrication of PLGA-based nanoparticles for promising delivery of Capecitabine for antitumor activity.
Jena GK; Patra CN; Panigrahi KC; Sruti J; Patra P; Parhi R
Drug Deliv Transl Res; 2022 Jun; 12(6):1521-1539. PubMed ID: 34505271
[TBL] [Abstract][Full Text] [Related]
4. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
5. Lyophilized SLN of Cinnacalcet HCl: BBD enabled optimization, characterization and pharmacokinetic study.
Routray SB; Patra CN; Raju R; Panigrahi KC; Jena GK
Drug Dev Ind Pharm; 2020 Jul; 46(7):1080-1091. PubMed ID: 32486863
[No Abstract] [Full Text] [Related]
6. Formulation design, optimization and
Hasija R; Chaurasia S; Gupta S
Pharm Dev Technol; 2021 Nov; 26(9):953-966. PubMed ID: 34374616
[TBL] [Abstract][Full Text] [Related]
7. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
Dudhipala N; Janga KY
Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
[TBL] [Abstract][Full Text] [Related]
8. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
Patil GB; Surana SJ
J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812
[TBL] [Abstract][Full Text] [Related]
9. Statistical optimization of tetrahydrocurcumin loaded solid lipid nanoparticles using Box Behnken design in the management of streptozotocin-induced diabetes mellitus.
Bharti Sharma J; Bhatt S; Tiwari A; Tiwari V; Kumar M; Verma R; Kaushik D; Virmani T; Kumar G; Al Kamaly O; Saleh A; Khalid Parvez M; Alhalmi A
Saudi Pharm J; 2023 Sep; 31(9):101727. PubMed ID: 37638219
[TBL] [Abstract][Full Text] [Related]
10. Improved Ocular Bioavailability of Moxifloxacin HCl using PLGA Nanoparticles: Fabrication, Characterization,
Khan FU; Nasir F; Iqbal Z; Neau S; Khan I; Hassan M; Iqbal M; Ullah A; Khan SI; Sakhi M
Iran J Pharm Res; 2021; 20(3):592-608. PubMed ID: 34904011
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of ketoconazole in lipid nanoparticles for enhanced antifungal activity and bioavailability through oral administration for management of fungal infections.
Dudhipala N; Ay AA
Chem Phys Lipids; 2020 Oct; 232():104953. PubMed ID: 32814084
[TBL] [Abstract][Full Text] [Related]
12. Loteprednol Etabonate Nanoparticles: Optimization via Box-Behnken Design Response Surface Methodology and Physicochemical Characterization.
Sah AK; Suresh PK
Curr Drug Deliv; 2017; 14(5):676-689. PubMed ID: 27480117
[TBL] [Abstract][Full Text] [Related]
13. Solid Lipid Nanoparticles Approach for Lymphatic Targeting Through Intraduodenal Delivery of Quetiapine Fumarate.
Yasir M; Gaur PK; Puri D; Shehkar P; Kumar SS
Curr Drug Deliv; 2018; 15(6):818-828. PubMed ID: 28545354
[TBL] [Abstract][Full Text] [Related]
14. Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters.
Cunha S; Costa CP; Loureiro JA; Alves J; Peixoto AF; Forbes B; Sousa Lobo JM; Silva AC
Pharmaceutics; 2020 Jun; 12(7):. PubMed ID: 32605177
[TBL] [Abstract][Full Text] [Related]
15. QbD-enabled systematic development of gastroretentive multiple-unit microballoons of itopride hydrochloride.
Bansal S; Beg S; Asthana A; Garg B; Asthana GS; Kapil R; Singh B
Drug Deliv; 2016; 23(2):437-51. PubMed ID: 24865292
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable nano-architectural PEGylated approach for the improved stability and anticancer efficacy of bendamustine.
Khan I; Gothwal A; Sharma AK; Qayum A; Singh SK; Gupta U
Int J Biol Macromol; 2016 Nov; 92():1242-1251. PubMed ID: 27527691
[TBL] [Abstract][Full Text] [Related]
17. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
Patel PJ; Gajera BY; Dave RH
Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
[TBL] [Abstract][Full Text] [Related]
18. Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation.
Yadav KS; Sawant KK
Curr Drug Deliv; 2010 Jan; 7(1):51-64. PubMed ID: 20044908
[TBL] [Abstract][Full Text] [Related]
19. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
[TBL] [Abstract][Full Text] [Related]
20. Formulation and Optimization of Alogliptin-Loaded Polymeric Nanoparticles: In Vitro to In Vivo Assessment.
Mohanty D; Gilani SJ; Zafar A; Imam SS; Kumar LA; Ahmed MM; Jahangir MA; Bakshi V; Ahmad W; Eltayib EM
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
